ATE116551T1 - Lebendes kombinationsvakzin. - Google Patents

Lebendes kombinationsvakzin.

Info

Publication number
ATE116551T1
ATE116551T1 AT89200382T AT89200382T ATE116551T1 AT E116551 T1 ATE116551 T1 AT E116551T1 AT 89200382 T AT89200382 T AT 89200382T AT 89200382 T AT89200382 T AT 89200382T AT E116551 T1 ATE116551 T1 AT E116551T1
Authority
AT
Austria
Prior art keywords
vaccin
live
live combination
viruses
combination
Prior art date
Application number
AT89200382T
Other languages
English (en)
Inventor
Carla Christina Schrier
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE116551T1 publication Critical patent/ATE116551T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT89200382T 1988-03-08 1989-02-17 Lebendes kombinationsvakzin. ATE116551T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/165,339 US5037650A (en) 1988-03-08 1988-03-08 Live combination vaccine

Publications (1)

Publication Number Publication Date
ATE116551T1 true ATE116551T1 (de) 1995-01-15

Family

ID=22598508

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89200382T ATE116551T1 (de) 1988-03-08 1989-02-17 Lebendes kombinationsvakzin.

Country Status (13)

Country Link
US (1) US5037650A (de)
EP (1) EP0332241B1 (de)
JP (2) JP2721005B2 (de)
KR (1) KR920005661B1 (de)
CN (2) CN1036838C (de)
AT (1) ATE116551T1 (de)
AU (1) AU614035B2 (de)
CA (1) CA1339963C (de)
DE (1) DE68920345T2 (de)
ES (1) ES2068883T3 (de)
HU (1) HU205265B (de)
NZ (1) NZ228232A (de)
ZA (1) ZA891371B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA978434B (en) * 1996-09-27 1998-03-26 Akzo Nobel Nv Inactivated vaccines.
KR100468037B1 (ko) * 2002-01-04 2005-01-24 학교법인 건국대학교 신규한 닭 전염성 기관지염 바이러스(ｉｂｖ) 및 이를이용한 닭 전염성 기관지염 (ｉｂ) 감염 예방백신
WO2007072916A1 (ja) * 2005-12-22 2007-06-28 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 卵内接種用ワクチン
GB2451428A (en) * 2007-07-25 2009-02-04 Pliva Hrvatska D O O Process for preparing an in ovo combination viral vaccine
AR072976A1 (es) * 2008-08-08 2010-10-06 Wyeth Corp Virus de bronquitis infecciosa (ib) aislado, composicion de vacuna y metodo para preparar un virus de bronquitis infecciosa (ib) atenuado vivo
CA2725435C (en) * 2009-12-15 2023-01-03 University Of Saskatchewan Vaccines for inclusion body hepatitis
GB201601498D0 (en) 2016-01-27 2016-03-09 Pirbright Inst The Coronavirus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798835A (en) * 1954-01-18 1957-07-09 American Cyanamid Co Newcastle disease and infectious bronchitis vaccines and production thereof
JPS587611B2 (ja) * 1973-07-26 1983-02-10 ザイダンホウジン カガクオヨビケツセイリヨウホウケンキユウシヨ カキンヨウコンゴウナマワクチン ノ セイゾウホウホウ
JPS54132226A (en) * 1978-04-04 1979-10-15 Biseibutsu Kagaku Kenkiyuushiy Raw virus vaccine for poutly infecting laryngth bronchus imflammatory
GB2114438A (en) * 1982-02-05 1983-08-24 Akzo Nv Infectious bronchitis vaccines
EP0212703B1 (de) * 1985-07-18 1991-09-04 Duphar International Research B.V Impfstoffe für einen Tag alte Hühner gegen die infektiöse Bronchitis

Also Published As

Publication number Publication date
CN1036838C (zh) 1997-12-31
JP2721005B2 (ja) 1998-03-04
JPH10175881A (ja) 1998-06-30
AU614035B2 (en) 1991-08-15
EP0332241B1 (de) 1995-01-04
CN1037838A (zh) 1989-12-13
HU205265B (en) 1992-04-28
NZ228232A (en) 1991-08-27
CN1101289A (zh) 1995-04-12
ES2068883T3 (es) 1995-05-01
ZA891371B (en) 1989-11-29
US5037650A (en) 1991-08-06
EP0332241A3 (en) 1990-05-16
AU3115189A (en) 1989-09-14
CA1339963C (en) 1998-07-21
DE68920345T2 (de) 1995-05-24
KR890014127A (ko) 1989-10-21
HUT52704A (en) 1990-08-28
DE68920345D1 (de) 1995-02-16
JP2887251B2 (ja) 1999-04-26
EP0332241A2 (de) 1989-09-13
KR920005661B1 (ko) 1992-07-13
JPH01272529A (ja) 1989-10-31

Similar Documents

Publication Publication Date Title
ES2152292T3 (es) Vacuna para aves de corral que contiene el virus de la bronquitis infecciosa 4/91.
DE3278344D1 (en) Stabilization of influenza virus vaccine
NO982861L (no) Stabilisatorer for levende vaksiner
DE3650289D1 (de) Spike-protein des virus der infektiösen bronchitis.
DK0588578T3 (da) Immunogener
NO159274C (no) Analogifremgangsmaate for fremstilling av fenyl-alifatisk-isoksazoler for bekjempelse av virus.
MY103575A (en) Cannie coronavirus vaccine
DK0838222T3 (da) Vaccinesammensætninger, der omfatter inaktiverede immunogener og levende kyllingeanæmi-virus (CAV)
ES8403319A1 (es) Nuevas vacunas contra la bronquitis infecciosa.
ATE116551T1 (de) Lebendes kombinationsvakzin.
ATE147632T1 (de) Impfstoff gegen den geflügelanämieerreger
ES467557A1 (es) Un procedimiento para la preparacion de una nueva vacuna queprotege a las aves ponedoras de huevos contra la enfermedad del descenso de la produccion de huevos.
ES2053477T3 (es) Vacuna viva para enfermedades contagiosas de pollos.
ES493433A0 (es) Procedimiento para la preparacion de vacunas de virus poli- valentes
ATE310078T1 (de) Hühner-anäemie-virus mit geringer pathogenität
FR2262511A1 (en) Vaccine against gosling hepatitis - prepd. from virus obtd. from liver or spleen of infected birds and grown in duckling or gosling embryo cells
ES2084587T3 (es) Arn virus no revertientes.
ATE86500T1 (de) Abgeschwaechtes virus und impfstoffe davon zur verwendung gegen infektionen bei gefluegel, verursacht durch truthahn-rhinotracheitis-virus.
NO882206D0 (no) Fremgangsmaate for fremstilling av levende eller inaktiverte rabiesvirusvaksiner.
NO891355D0 (no) Vaksinasjon mot rabis-beslektede virus.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time